Nomograms predicting progression-free survival, overall survival, and pelvic recurrence in locally advanced cervical cancer developed from an analysis of identifiable prognostic factors in patients from NRG oncology/gynecologic oncology group randomized trials of chemoradiotherapy

Journal of Clinical Oncology

Volumn 33, Issue 19, 2015, Pages 2136-2142

  Rose, Peter G ^a   Java, James ^b   Whitney, Charles W ^c   Stehman, Frederick B ^d   Lanciano, Rachelle ^e   Thomas, Gillian M ^f   DiSilvestro, Paul A ^g  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Delaware County Regional Cancer Center   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BOOTSTRAPPING; CALIBRATION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; ETHNICITY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; NOMOGRAM; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TUMOR VOLUME; UTERINE CERVIX CANCER; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE; UTERINE CERVICAL NEOPLASMS;

ADULT; ANTINEOPLASTIC AGENTS; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84937115326     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.57.7122     Document Type: Article

References (22)

1. Delgado G, Bundy B, Zaino R, et al: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352-357, 1990
2. Stehman FB, Bundy BN, DiSaia PJ, et al: Carcinoma of the cervix treated with radiation therapy: I. A multivariate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776-2785, 1991
3. National Institutes of Health: NCI issues clinical announcement on cervical cancer: Chemotherapy plus radiation improves survival. http://www.nih.gov/news/pr/feb99/nci-22.htm
4. Whitney CW, Sause W, Bundy BN, et al: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339-1348, 1999
5. Rose PG, Bundy BN, Watkins EB, et al: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144-1153, 1999
6. Keys HM, Bundy BN, Stehman FB, et al: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154-1161, 1999
7. Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606-1613, 2000
8. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137-1143, 1999
9. National Comprehensive Cancer Network: NCCN guideline for locally advanced cervical cancer. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp
10. Lanciano R, Calkins A, Bundy BN, et al: Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: A Gynecologic Oncology Group study. J Clin Oncol 23:8289-8295, 2005
11. Thomas G, Ali S, Hoebers FJ, et al: Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 108:317-325, 2008
12. DiSilvestro PA, Ali S, Craighead PS, et al: Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: A Gynecologic Oncology Group study. J Clin Oncol 32:458-464, 2014
13. Pearson K: On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. Philosophical Magazine Series 5 50:157-175, 1900
14. Mann HB, Whitney DR: On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50-60, 1947
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-220, 1972
17. Chen JL, Cheng JC, Kuo SH, et al: Outcome analysis of cervical adenosquamous carcinoma compared with adenocarcinoma. Acta Obstet Gynecol Scand 91:1158-1166, 2012
18. Lawless JF, Singhal K: Efficient screening of nonnormal regression models. Biometrics 34:318-327, 1978
19. Harrell FE Jr, Califf RM, Pryor DB, et al: Evaluating the yield of medical tests. JAMA 247: 2543-2546, 1982
20. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996
21. Harrell FE, Lee KL: A comparison of the discrimination of discriminant analysis and logistic regression under multivariate normality, in Sen PK (ed): Biostatistics: Statistics in Biomedical, Public Health and Environmental Sciences. Amsterdam, the Netherlands, North-Holland, 1985, pp 333-343
22. Abu-Rustum NR, Lee S, Correa A, et al: Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 81:88-91, 2001